Specific proteome changes in platelets from individuals with GATA1-, GFI1B-, and RUNX1-linked bleeding disorders.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
08 07 2021
Historique:
received: 17 07 2020
accepted: 04 03 2021
pubmed: 11 3 2021
medline: 31 7 2021
entrez: 10 3 2021
Statut: ppublish

Résumé

Mutations in the transcription factors GATA binding factor 1 (GATA1), growth factor independence 1B (GFI1B), and Runt-related transcription factor 1 (RUNX1) cause familial platelet and bleeding disorders. Mutant platelets exhibit common abnormalities including an α-granule reduction resulting in a grayish appearance in blood smears. This suggests that similar pathways are deregulated by different transcription factor mutations. To identify common factors, full platelet proteomes from 11 individuals with mutant GATA1R216Q, GFI1BQ287*, RUNX1Q154Rfs, or RUNX1TD2-6 and 28 healthy controls were examined by label-free quantitative mass spectrometry. In total, 2875 platelet proteins were reliably quantified. Clustering analysis of more than 300 differentially expressed proteins revealed profound differences between cases and controls. Among cases, 44 of 143 significantly downregulated proteins were assigned to platelet function, hemostasis, and granule biology, in line with platelet dysfunction and bleedings. Remarkably, none of these proteins were significantly diminished in all affected cases. Similarly, no proteins were commonly overrepresented in all affected cases compared with controls. These data indicate that the studied transcription factor mutations alter platelet proteomes in distinct largely nonoverlapping manners. This work provides the quantitative landscape of proteins that affect platelet function when deregulated by mutated transcription factors in inherited bleeding disorders.

Identifiants

pubmed: 33690840
pii: S0006-4971(21)00638-8
doi: 10.1182/blood.2020008118
doi:

Substances chimiques

Core Binding Factor Alpha 2 Subunit 0
GATA1 Transcription Factor 0
GATA1 protein, human 0
GFI1B protein, human 0
Proteome 0
Proto-Oncogene Proteins 0
Repressor Proteins 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-90

Informations de copyright

© 2021 by The American Society of Hematology.

Auteurs

M G J M Van Bergen (MGJM)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

A E Marneth (AE)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Department of Medicine, Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

A J Hoogendijk (AJ)

Molecular Hematology and.

F P J Van Alphen (FPJ)

Molecular Hematology and.

E Van den Akker (E)

Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.

B A P Laros-Van Gorkom (BAP)

Department of Hematology, Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Nijmegen, The Netherlands.

M Hoeks (M)

Department of Hematology, Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Nijmegen, The Netherlands.

A Simons (A)

Department of Genetics, Radboudumc, Nijmegen, The Netherlands.

S A De Munnik (SA)

Department of Genetics, Radboudumc, Nijmegen, The Netherlands.

J J W M Janssen (JJWM)

Department of Hematology, Amsterdam University Medical Centers (UMC), Amsterdam, The Netherlands; and.

J H A Martens (JHA)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.

J H Jansen (JH)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

A B Meijer (AB)

Molecular Hematology and.

B A Van der Reijden (BA)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH